Given that SUZ12 is a core regulator of PRC2-mediated gene silencing, its dysregulation in CHD/T2D suggests that epigenetic dysregulation could be a significant factor in the pathogenesis and progression of these diseases. The gene discussed is SUZ12; the disease is type 2 diabetes mellitus.